Infanrix Polio

Pertussis Toxoid Adsorbed on Aluminium Hydroxide and Pertussis Pertactin Adsorbed on Aluminium Hydroxide, the active ingredients in Infanrix Polio, are vaccine components presented as a combination diphtheria, tetanus, pertussis and poliomyelitis vaccine for intramuscular use. They stimulate active immunity against diphtheria toxin, tetanus toxin, pertussis antigens, and poliovirus, helping prevent these infections in infants and children.

GNH USA supplies Infanrix Polio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infanrix Polio is a combination vaccine that targets bacterial toxins and poliovirus to prevent several childhood diseases. - Diphtheria: provides active immunity to prevent diphtheria infection. - Tetanus: induces antibodies that protect against tetanus toxin. - Pertussis (whooping cough): stimulates protection against Bordetella pertussis. - Poliomyelitis: generates immunity that blocks poliovirus replication.

Common Side Effects: - Injection site pain, redness or swelling. - Low‑grade fever. - Irritability or fussiness in infants. - Decreased appetite. - Mild rash at the injection site.

Serious or Rare Side Effects: - Anaphylactic reaction (severe allergic response). - Seizures or high‑grade fever. - Prolonged crying episodes. - Hypotonic‑hyporesponsive episodes. - Encephalopathy or neurologic complications. - Severe local inflammation requiring medical attention.

Infanrix Polio should be administered according to national immunisation schedules and under professional supervision. - Age: give only to infants and children as recommended by health authorities. - Allergy: avoid if the patient has a known hypersensitivity to any vaccine component. - Medical conditions: consult a healthcare provider for children with severe immunodeficiency. - Concurrent vaccines: can be co‑administered with other routine vaccines following guideline timing. - Pregnancy: not indicated for pregnant women; discuss risks with a clinician. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Infanrix Polio may interact with other agents that affect immune response. Major Interactions (Avoid): - Live attenuated vaccines: avoid simultaneous administration. - Immunoglobulins: may reduce vaccine efficacy if given within two weeks. - Blood products: can interfere with immune response if administered shortly before or after vaccination. Moderate Interactions (Monitor Closely): - Antipyretics: may mask post‑vaccination fever. - High‑dose corticosteroids: could diminish antibody production. - Other vaccines: schedule spacing as per immunisation guidelines.